PRONEXUS
Desconocido
BATCure: Developing new therapies for Batten disease
PRONEXUS ANALYTICAL AB
participó en un
H2020:
H2020-PHC-2014-2015
The goal of BATCure is to advance the development of new therapeutic options for a group of rare lysosomal diseases - neuronal ceroid lipofu...
2015-12-04 - 2019-06-30 | Financiado
2015-12-04 - 2019-06-30 | Financiado
HUMAN: Health and the Understanding of Metabolism Aging and Nutrition
PRONEXUS ANALYTICAL AB
participó en un
FP7:
Recently intense research identified around 4,000 single nucleotide polymorphisms (SNPs) associated with human age related diseases such as...
Financiado
Financiado
* No se disponen de datos de la empresa actual.